×
0.000155062800434035 0 -0.000155062800434255 -0.000837339122344581 -0.00255388432315104 -0.00093037680260509 -0.00093037680260509 -0.00093037680260509
Stock impact report

AbbVie prices new rheumatoid arthritis drug at $59,000/yr [Reuters (UK)]

AbbVie, Inc (ABBV)  More Company Research Source: Reuters
Last abbvie, inc earnings: 11/1 07:47 am Check Earnings Report
US:NYSE Investor Relations: investors.abbvie.com/investor-overview
PDF AbbVie prices new rheumatoid arthritis drug at $59,000/yr - Reuters 3 Min Read (Reuters) - AbbVie Inc has priced its new rheumatoid arthritis treatment at $59,000 a year after gaining U.S. approval on Friday, a big boost for the drugmaker struggling with rising competition for Humira, its blockbuster therapy for the same condition. A four-week supply of Humira, the world’s best-selling medicine, has a list price of about $5,174, amounting to more than $60,000 for a year. However, the list price is not necessarily what patients actually pay as “out-of-pocket” costs vary based on the duration of the treatment and individual healthcare plans. Humira brought in global revenue of $4.87 billion in the second quarter, but sales have been hit by competition from cheaper rivals in Europe, and AbbVie in June announced a deal to buy Botox-maker Allergan Plc for $63 billion to reduce dependence on the drug. The company has signed deals to prevent cheaper versions of Humira, which also treats psor [Read more]
Impact snapshot Event time: ABBV
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
ABBV alerts
from News Quantified
Opt-in for
ABBV alerts

from News Quantified
Opt-in for
ABBV alerts

from News Quantified